Sakalauskaite Sandra, Zdanavicius Linas, Šteinmiller Jekaterina, Istomina Natalja
Laboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.
Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Int J Environ Res Public Health. 2025 Jun 26;22(7):1010. doi: 10.3390/ijerph22071010.
Tobacco control policies have aimed to reduce the global prevalence of smoking. Unfortunately, the recent survey data shows that about 24% of Europeans still smoke. Although combustible cigarettes remain the most used tobacco product, the tendency made evident in the prevalence of smoking-alternative nicotine-containing products increases. Studies that can objectively assess the long-term health effects of the latter products are lacking, so assessing toxic substances associated with smoking-alternative products and comparing them to substances from combustible cigarettes could inform future public health efforts. The manufacturers of these alternative products claim that the use of alternatives to combustible cigarettes reduces exposure to toxic compounds, but the reality is unclear. This study compares the concentrations of toxic substances in generated aerosols and performs calculations based on mainstream cigarette smoke and aerosols from smoking-alternative products. It summarizes the amounts of harmful and potentially harmful constituents per single puff. Alternative smoking products are undoubtedly harmful to non-smokers. Still, based on the analysis of the latest independent studies' empirical data, the concentrations of inhaled HPHCs using heated tobacco products or e-cigarettes are reduced up to 91-98%, respectively; therefore, for those who cannot quit, these could provide a less harmful alternative. However, more well-designed studies of alternative product emissions are needed, including an analysis of the compounds that are not present in conventional tobacco products (e.g., thermal degradation products of propylene glycol, glycerol, or flavorings) to evaluate possible future health effects objectively.
烟草控制政策旨在降低全球吸烟率。不幸的是,最近的调查数据显示,约24%的欧洲人仍在吸烟。尽管可燃香烟仍是使用最广泛的烟草产品,但含尼古丁的替代吸烟产品的流行趋势日益明显。目前缺乏能够客观评估这些产品长期健康影响的研究,因此评估与替代吸烟产品相关的有毒物质,并将其与可燃香烟中的物质进行比较,可为未来的公共卫生工作提供参考。这些替代产品的制造商声称,使用可燃香烟的替代品可减少有毒化合物的接触,但实际情况尚不清楚。本研究比较了产生的气溶胶中有毒物质的浓度,并根据主流香烟烟雾和替代吸烟产品产生的气溶胶进行计算。它总结了每一口吸入的有害和潜在有害成分的量。替代吸烟产品无疑对非吸烟者有害。不过,根据对最新独立研究实证数据的分析,使用加热烟草产品或电子烟吸入的有害和潜在有害化学物质(HPHCs)浓度分别降低了91%至98%;因此,对于那些无法戒烟的人来说,这些产品可能是危害较小的替代品。然而,需要更多精心设计的关于替代产品排放的研究,包括对传统烟草产品中不存在的化合物(如丙二醇、甘油或调味剂的热降解产物)的分析,以客观评估未来可能的健康影响。